Assenagon Asset Management S.A. Lowers Stock Position in The Clorox Company $CLX

Assenagon Asset Management S.A. trimmed its position in shares of The Clorox Company (NYSE:CLX) by 84.1% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 43,602 shares of the company’s stock after selling 230,072 shares during the period. Assenagon Asset Management S.A.’s holdings in Clorox were worth $4,518,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Vermillion & White Wealth Management Group LLC acquired a new position in Clorox in the third quarter valued at $25,000. Darwin Wealth Management LLC acquired a new stake in Clorox during the second quarter worth about $29,000. Caitlin John LLC raised its holdings in shares of Clorox by 1,807.1% in the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock worth $27,000 after purchasing an additional 253 shares during the period. Ameriflex Group Inc. lifted its stake in shares of Clorox by 1,436.8% in the 3rd quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock valued at $36,000 after purchasing an additional 273 shares in the last quarter. Finally, Vision Financial Markets LLC lifted its stake in shares of Clorox by 166.7% in the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after purchasing an additional 200 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Trading Down 0.5%

CLX opened at $97.10 on Tuesday. The firm has a market capitalization of $11.74 billion, a P/E ratio of 15.76, a P/E/G ratio of 0.51 and a beta of 0.56. The firm’s 50 day moving average is $94.57 and its 200-day moving average is $104.42. The Clorox Company has a 52-week low of $84.70 and a 52-week high of $132.03. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03.

Clorox (NYSE:CLX) last announced its earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.09. The business had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The business’s quarterly revenue was up .1% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Analysts expect that The Clorox Company will post 5.61 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director Pierre R. Breber acquired 5,000 shares of the firm’s stock in a transaction on Tuesday, May 5th. The stock was bought at an average cost of $85.82 per share, with a total value of $429,100.00. Following the transaction, the director directly owned 18,000 shares in the company, valued at approximately $1,544,760. This represents a 38.46% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.63% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the company. The Goldman Sachs Group reissued a “sell” rating and set a $83.00 target price on shares of Clorox in a research report on Friday, May 1st. Weiss Ratings raised shares of Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, April 13th. Morgan Stanley decreased their price objective on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research note on Friday, May 1st. Barclays dropped their price objective on shares of Clorox from $102.00 to $85.00 and set an “underweight” rating for the company in a research report on Friday, May 1st. Finally, Zacks Research downgraded shares of Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, May 12th. One research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Reduce” and a consensus price target of $103.40.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.